DrugPatentWatch

Search for Patent: 5,641,805

Summary for Patent: 5,641,805

Title: Topical ophthalmic formulations for treating allergic eye diseases
Abstract:Topical ophthalmic formulations of the invention contain as an active ingredient
11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid or a pharmaceutically acceptable salt thereof. The formulations are useful
for treating allergic eye diseases such as allergic conjunctivitis, vernal conjunctivitis, vernal keratoconjunctivitis, and giant papillary
conjunctivitis.
Inventor(s): Hayakawa; Eiji (Susono, JP), Nakakura; Masashi (Shizuoka-ken, JP), Robertson; Stella M. (Arlington, TX), Yanni; John Michael (Burleson, TX)
Assignee: Alcon Laboratories, Inc. (Fort Worth, TX) Kyowa Hakko Kogyo Co. Ltd. (Tokyo, JP)
Application Number:08/469,729
Patent Claim Types:Use; Composition; Formulation;
Patent PDF download available with subscription

 

Glossary
Applicant Tradename Generic Name NDA Approval Date Type RLD Patent Number Product Substance Delist Req. Patent Expiration Patented / Exclusive Use
AlconPATADAYolopatadine hydrochloride021545Dec 22, 2004RXYes5,641,805*PEDYDec 6, 2015
AlconPATANOLolopatadine hydrochloride020688Dec 18, 1996RXYes5,641,805*PEDYDec 6, 2015
Export available with Ultimate Plan subscription: 

This preview shows a limited data set. Complete access is available with a Subscription

<- Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:
 2000  2001  2002  2003  2004 
 2005  2006  2007  2008  2009 


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright © 2000-2010, thinkBiotech LLC.


[ Home | Site Tour | Plan Comparison | Free Patent Expiration Newsletter | Patent Inventor Report | Contact ]
Drug Patent ExpirationsFollow DrugPatentWatch on Twitter
Bookmark or Share This Page ...
[del.icio.us] [Digg] [Reddit] [Facebook] [LinkedIn] [StumbleUpon] [Technorati] [Twitter] [Email]